Markets.com Logo

XERS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    7.5312$
  • Previous Close
    7.6635$
  • 52 Week Change
    5.31$
  • Day Range
    -0.13$
  • 52 Week High/Low
    2.48$ - 7.79$
  • Dividend Per Share
    --
  • Market cap
    1 226 M$
  • EPS
    -0.01
  • Beta
    0.86
  • Volume
    --

About

XERS.US refers to Xeris Biopharma Holdings, Inc., a biopharmaceutical company that develops and commercializes ready-to-use injectable and infusible drug formulations. The company's proprietary XeriSol and XeriJect technology platforms are used to create stable liquid formulations of drugs that are typically unstable or insoluble in water, enabling subcutaneous or intramuscular injections without reconstitution. Xeris Biopharma focuses on therapies for endocrinology, neurology, and gastroenterology and has several approved products and pipeline candidates addressing unmet medical needs.
Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?

Crypto market analysis: AAVE price AAVE/ZAR surges, what’s happening with the crypto market in South Africa?

Ghko B|--
Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders

Liquidity, Costs, and Execution: A Comparative Analysis of JSE and A2X for ZA Traders

Ghko B|--
ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

Ghko B|--
Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Ghko B|--

Oil Market Paradox: Geopolitical Tensions vs. Stable Prices

Ava Grace|--

US Midterm Elections: Energy Sector Outlook and Investment Implications

Ava Grace|--
Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Ghko B|--

Factors

Company Performance: Xeris Biopharma's financial health, including revenue, profit margins, and debt levels, directly impacts its stock price.

Drug Pipeline: Progress on clinical trials and FDA approvals for Xeris's drug candidates significantly influences investor confidence and valuation.

Market Conditions: Broader economic trends, investor sentiment, and industry-specific factors affect all stocks, including XERS.US.

Competition: The presence of competing drugs and therapies can impact Xeris's market share and pricing power.

Regulatory Environment: Changes in regulations related to pharmaceuticals and healthcare can have a positive or negative effect.

News and Events: Company-specific announcements, press releases, and media coverage influence short-term stock price movements.

Investor Sentiment: The overall mood and expectations of investors regarding Xeris Biopharma's future prospects affect demand and supply.

People Also Watch

Latest news

Commodity Market Today: UAE to Leave OPEC After Nearly 60 Years in Major Blow to Oil Cartel

Commodity Market Today: UAE to Leave OPEC After Nearly 60 Years in Major Blow to Oil Cartel

Ghko B|--
Gold Price Today, April 30: XAUUSD Hits $4,575 Amid Escalating Global Economic Uncertainty

Gold Price Today, April 30: XAUUSD Hits $4,575 Amid Escalating Global Economic Uncertainty

Ghko B|--
Apple (AAPL) Q2 FY26 is coming: What’s going on with the Apple Supply Chain Stocks?

Apple (AAPL) Q2 FY26 is coming: What’s going on with the Apple Supply Chain Stocks?

Ghko B|--

Latest Education Articles

What Is Mirror Trading and How Does It Work?

What Is Mirror Trading and How Does It Work?

Julian Parker|--
What Is Short Selling? How Shorting Works in CFD Trading

What Is Short Selling? How Shorting Works in CFD Trading

Julian Parker|--
Leverage vs Margin Trading: Key Differences, Examples and Risks

Leverage vs Margin Trading: Key Differences, Examples and Risks

Julian Parker|--
Recommended Topics